Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis

Background: To compare the efficacy and safety of advanced intravitreal therapeutic regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide (FA) implant, 0.2 µg/day, 0.59 and 2.1 mg; intravitreal bevacizumab, 1.25 mg; intravitreal ranibizumab, 0.5 mg; intravitreal tri...

Full description

Bibliographic Details
Main Authors: Weiting Liao, Zhenyu Zhong, Guannan Su, Xiaojie Feng, Peizeng Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
drug implants
intravitreal agents
drug delivery system (DDS)
steroid
anti-VEGF (vascular endothelial growth factor) agents
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.749312/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.749312/full

Similar Items